HaythemYAliMD

Oncology • Troy, MI

Breast Cancer, Head & Neck Cancer, Hematologic Oncology

Physician

Join to view full profile

Dr. Ali is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Ali's full profile

Already have an account?

Office
2825 Livernois Rd
Troy, MI 48083
Phone+1 313-916-2600
Is this information wrong?

Education & Training

Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 1996 - 1998
Ascension Providence/MSUCHMResidency, Internal Medicine, 1993 - 1996
University of Baghdad College of MedicineClass of 1988

Certifications & Licensure

MI State Medical License 1995 - 2024
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013

Clinical Trials

Erlotinib (Tarceva) During First Line Standard Platinum Containing Chemo for Advanced Squamous Cell Head and Neck Cancer Start of enrollment: 2007 Feb 01
Terminated
Phase 2, Phase 3
Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity Start of enrollment: 2010 Dec 01
Completed
Phase 3
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol Start of enrollment: 2014 Mar 01
Unknown status
CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448) Start of enrollment: 2015 Aug 01
Completed
Phase 1, Phase 2
Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC Start of enrollment: 2017 Dec 21
Terminated
Phase 3
A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer Start of enrollment: 2021 May 10
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Immunotherapy Enhancement by Targeting Extracellular Tumor pH in Triple-Negative Breast Cancer Mouse Model.
Azizur Rahman, Branislava Janic, Tasnim Rahman, Harshit Singh, Haythem Ali, Ramandeep Rattan, Mohsin Kazi, Meser M Ali> ;Cancers. 2023 Oct 11
1 citations
Short-term changes in ultrasound tomography measures of breast density and treatment-associated endocrine symptoms after tamoxifen therapy.
Cody Ramin, Ruth M Pfeiffer, Sharon Fan, Maeve Mullooly, Roni T Falk, Kristine Jones, Neil E Caporaso, Lisa Bey-Knight, Mark A Sak, Michael S Simon, David H Gorski, Ha...> ;NPJ Breast Cancer. 2023 Mar 15
2 citations
A phase I clinical trial of oncolytic adenovirus mediated suicide and interleukin-12 gene therapy in patients with recurrent localized prostate adenocarcinoma.
Shyam Nyati, Hans Stricker, Kenneth N Barton, Pin Li, Mohamed Elshaikh, Haythem Ali, Stephen L Brown, Clara Hwang, James Peabody, Svend O Freytag, Benjamin Movsas, Far...> ;Plos One. 2023 Jan 1
2 citations
Cetuximab and anemia prevention in head and neck cancer patients undergoing radiotherapy.
Lucas Maahs, Ahmed I Ghanem, Radhika Gutta, Amy Tang, Swarn Arya, Zaid Al Saheli, Haythem Ali, Steven Chang, Samantha Tam, Vivian Wu, Farzan Siddiqui, Jawad Sheqwara> ;BMC Cancer. 2022 Jun 7
3 citations
Rapid Reductions in Breast Density following Tamoxifen Therapy as Evaluated by Whole-Breast Ultrasound Tomography.
Gretchen L Gierach, Mark Sak, Shaoqi Fan, Ruth M Pfeiffer, Maya Palakal, Cody Ramin, Lisa Bey-Knight, Michael S Simon, David Gorski, Haythem Ali, Peter Littrup, Mark E...> ;Journal of Clinical Medicine. 2022 Feb 1
4 citations
Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer.
Genevieve A Fasano, Solange Bayard, Yalei Chen, Leticia Varella, Tessa Cigler, Jessica Bensenhaver, Rache Simmons, Alexander Swistel, Jennifer Marti, Anne Moore, Eleni...> ;Breast Cancer Research and Treatment. 2022 Feb 1
10 citations
Randomized Phase III, Double Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal ...
Andrew Cook, Ankit Modh, Haythem Ali, Jawad Sheqwara, Steven S. Chang, Tamer Ghanem, Suhael Momin, Vivian F. Wu, Samantha Tam, Sarah Money, Xiaoxia Han, Lamis Fakhoury...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Nov 19
3 citations
Clinical significance of quantitative categorization of HER2 fluorescent in situ hybridization results in invasive breast cancer patients treated with HER2-targeted ag...
Mohamed Alhamar, Bassam Alkamachi, Harshita Mehrotra, Jessica Sanchez, Haythem Ali, Daniel Schultz, Dhananjay Chitale> ;Modern Pathology. 2021 Jan 21
Acceptability and Feasibility of an Isometric Resistance Exercise Program for Abdominal Cancer Surgery: An Embedded Qualitative Study:
Ferhana Hashem, David Stephensen, Amanda Bates, Tracy Pellatt-Higgins, Ralph Nobby Peter Hobbs, Malcolm Hopkins, Hazel Woodward, Charitini Stavropoulou, Ian L. Swaine,...> ;Cancer Control. 2020 Oct 9
The importance of cancer patients' functional recollections to explore the acceptability of an isometric-resistance exercise intervention: A qualitative study
Ferhana Hashem, Kevin Corbett, David Stephensen, Ian L. Swaine, Haythem Ali, Irena Hutchins> ;Health Science Reports. 2020 Sep 1
18 citations
Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed
Neb Duric, Mark Sak, Shaoqi Fan, Ruth M. Pfeiffer, Peter Littrup, Michael S. Simon, David H. Gorski, Haythem Ali, Kristen S. Purrington, Rachel F. Brem, Mark E. Sherma...> ;Journal of Clinical Medicine. 2020 Jan 29
1458 citations
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048) : a ...
Barbara Burtness, Kevin J. Harrington, Richard Greil, Denis Soulières, Makoto Tahara, Gilberto de Castro, Amanda Psyrri, Neus Baste, Prakash Neupane, Åse Bratland, Tho...> ;Lancet. 2019 Nov 23
4 citations
Distribution and Short‐term Prognostic Value of the 21‐gene recurrence score in African American compared to White American breast cancer patients
Ali Amro, Yalei Chen, Renee Barry, Laura L Susick, Jessica Bensenhaver, Erica Proctor, Lindsay Petersen, S. David Nathanson, Haythem Ali, Randa Loutfi, Dhananjay Chita...> ;The Breast Journal. 2019 Jul 1
24 citations
Tumor antigen-independent and cell size variation-inclusive enrichment of viable circulating tumor cells
Wujun Zhao, Yang Liu, Brittany D. Jenkins, Rui Cheng, Bryana N. Harris, Weizhong Zhang, Jin Xie, Jonathan R. Murrow, Jamie Hodgson, Mary Egan, Ana Bankey, Petros Nikol...> ;Lab on a Chip. 2019 May 14
6 citations
Evaluation of a Multidisciplinary Team Approach for Generating Survivorship Care Plan Treatment Summaries in Patients With Breast Cancer.
Tommy Ivanics, Erica Proctor, Yalei Chen, Haythem Ali, Dawn Severson, Hassan Nasser, Sonja Colbert, Laura L Susick, Eleanor M. Walker, Lindsay Petersen, Jessica Bensen...> ;Journal of Oncology Practice. 2019 Apr 4
35 citations
Atypical Chemokine Receptor 1 (DARC/ACKR1) in Breast Tumors Is Associated with Survival, Circulating Chemokines, Tumor-Infiltrating Immune Cells, and African Ancestry
Brittany D. Jenkins, Rachel Martini, Rupali Hire, Andrea Brown, Briana Bennett, I'nasia Brown, Elizabeth W. Howerth, Mary Egan, Jamie Hodgson, Clayton Yates, Rick A. K...> ;Cancer Epidemiology, Biomarkers & Prevention. 2019 Apr 1
A Lesion on the Scalp.
Zaid Abdel-Rahman, Kedar V. Inamdar, Haythem Ali> ;JAMA Oncology. 2019 Jan 1
14 citations
A Noninvasive Blood-based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment
Meredith C. Henderson, Michael Silver, Quynh Tran, Elias Letsios, Rao Mulpuri, David E. Reese, Ana Lourenço, Joshua LaBaer, Karen S. Anderson, Josie Alpers, Carrie Cos...> ;Clinical Cancer Research. 2019 Jan 1
147 citations
Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial
Janusz Jankowski, John de Caestecker, Sharon Love, Gavin Reilly, Peter Watson, Scott Sanders, Yeng Ang, Danielle Morris, Pradeep Bhandari, Claire Brooks, Stephen Attwo...> ;Lancet. 2018 Aug 4
83 citations
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: r...
Denise A. Yardley, Robert E. Coleman, Pierfranco Conte, J. Cortes, Adam Brufsky, Mikhail Shtivelband, Robyn R. Young, Carmelo Bengala, Haythem Ali, J. Eakel, Andreas S...> ;Annals of Oncology. 2018 Aug 1
9 citations
nab-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.PS2 Study in Patients With NSCLC and a Performance Status of 2.
Ajeet Gajra, Nagla Abdel Karim, Deborah Mulford, Liza C. Villaruz, Marc R. Matrana, Haythem Ali, Edgardo S. Santos, Tymara Berry, Teng Jin Ong, Alexandra Sanford, Kata...> ;Frontiers in Oncology. 2018 Jul 24
30 citations
Phase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
Aditya Bardia, Ayca Gucalp, Noashir DaCosta, Nashat Gabrail, Michael A. Danso, Haythem Ali, Kimberly L. Blackwell, Lisa A. Carey, Joel R. Eisner, Edwina Baskin-Bey, Ti...> ;Breast Cancer Research and Treatment. 2018 May 9
8 citations
Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Res...
Ko-Un Park, Yalei Chen, Dhananjay Chitale, Sarah Choi, Haythem Ali, S. David Nathanson, Jessica Bensenhaver, Erica Proctor, Lindsay Petersen, Randa Loutfi, Alyson Simo...> ;Annals of Surgical Oncology. 2018 Apr 20
10 citations
Effects of preoperative and postoperative resistance exercise interventions on recovery of physical function in patients undergoing abdominal surgery for cancer: a sys...
David Stephensen, Ferhana Hashem, Kevin Corbett, Amanda Bates, Michelle George, Ralph Nobby Peter Hobbs, Malcolm Hopkins, Irena Hutchins, David Lowery, Tracy Pellatt-H...> ;BMJ Open Sport & Exercise Medicine. 2018 Apr 1
18 citations
Harnessing a Different Dependency: How to Identify and Target Androgen Receptor-Positive Versus Quadruple-Negative Breast Cancer
Jessica L. Christenson, Jane B. Trepel, Haythem Ali, Sunmin Lee, Joel R. Eisner, Edwina Baskin-Bey, Anthony D. Elias, Jennifer K. Richer> ;Hormones & Cancer. 2018 Jan 16
Join now to see all

Journal Articles

Nab-Paclitaxel plus Carboplatin or Gemcitabine vs Gemcitabine plus Carboplatin as First-Line Treatment for Patients with Triple-Negative Metastatic Breast Cancer: Resu...
H Ali, A Brufsky, M Shtivelband, S Gluck, J Miller, R Young, Annals of Oncology

Lectures

A differential response to cetuximab in patients with recurrent unresectable or metastatic head and neck cancer following immunotherapy (IO) exposure: An institutional...
2019 ASCO Annual Meeting - 6/1/2019